Reaction
Change In Seizure Presentation reporting signals
As of the last recalculation, Change In Seizure Presentation appears in 648 FAERS reports alongside 26 co-occurring drug terms. The strongest observed disproportionality signal is CLOBAZAM (PRR 181.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Clobazam | 114 | 181.8 | 182.7 |
| Brivaracetam | 43 | 164.4 | 165.2 |
| Cannabidiol | 95 | 152.6 | 153.2 |
| Lacosamide | 115 | 120.5 | 120.8 |
| Levetiracetam In Sodium Chloride | 175 | 99.0 | 99.2 |
| Levetiracetam Oral | 175 | 99.0 | 99.2 |
| Levetiracetam Injection | 175 | 99.0 | 99.2 |
| Vigabatrin | 41 | 96.4 | 96.7 |
| Zonisamide | 40 | 92.5 | 92.7 |
| Levetiracetam | 233 | 86.9 | 87.1 |
| Cenobamate | 19 | 75.3 | 75.5 |
| Phenobarbital | 22 | 50.4 | 50.5 |
| Sevoflurane | 11 | 43.2 | 43.3 |
| Valproic Acid | 39 | 42.2 | 42.3 |
| Oxcarbazepine | 33 | 34.3 | 34.3 |
| Midazolam | 24 | 31.7 | 31.8 |
| Midazolam Hydrochloride | 24 | 29.7 | 29.7 |
| Lamotirigine | 60 | 29.5 | 29.6 |
| Lamotrigine Extended-Release | 60 | 29.5 | 29.6 |
| Lamotrigine Chewable Dispersible | 60 | 29.5 | 29.6 |
| Topiramate | 71 | 27.4 | 27.4 |
| Asenapine Maleate | 7 | 26.2 | 26.2 |
| Carbamazepine | 47 | 24.2 | 24.2 |
| Lamotrigine | 86 | 24.0 | 24.0 |
| Guanfacine | 4 | 16.4 | 16.4 |
| Lurasidone Hydrochloride | 7 | 10.9 | 10.9 |